Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2021-02-09 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 90% confidence The document is a press release dated February 9, 2021, announcing the publication of two clinical studies related to the company's product, Cellvizio, concerning pancreatic cysts. It details scientific findings and quotes management. This format—a news announcement highlighting recent developments, often including financial or operational updates, and referencing external publications—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (10-K, IR), a transcript (CT), or a specific management compensation report (DEF 14A), and it is announcing positive operational/scientific news rather than just the *release* of a report (RPA), it fits best as an Earnings Release (ER) if it's tied to a reporting period, or RNS if it's purely operational news. Given the date and the nature of announcing significant clinical validation, it functions as a key operational update often bundled with earnings announcements, but since it doesn't explicitly state 'Earnings Release' or cover a full fiscal period summary, the most appropriate general category for significant, non-standard announcements is RNS, or ER if we assume it's a supplementary release. However, looking closely at the content, it is a press release announcing scientific/clinical progress, not a formal earnings summary. Therefore, RNS (Regulatory Filings/General Announcement) is the safest classification, as it doesn't fit the specific financial report types.
2021-02-09 French
Inside Information / Other news releases
Regulatory Filings Classification · 92% confidence The document is a press release from Mauna Kea Technologies dated February 09, 2021, announcing the publication of two peer-reviewed studies related to their Cellvizio platform and pancreatic cyst diagnosis. It details clinical findings and quotes the CEO. This type of announcement, which communicates recent developments, clinical validation, or financial highlights outside of a formal periodic report (like 10-K or IR), most closely aligns with an Earnings Release (ER) if it were tied to quarterly results, or more generally, a Regulatory Filing (RNS) if it's a general corporate update. Since it is not a formal financial report (10-K, IR, MRQ) but rather an announcement of scientific validation and publication, and it doesn't fit the specific categories like DIV, CAP, or MANG, the most appropriate general category for a significant corporate/scientific update that isn't a formal earnings report is RNS (Regulatory Filings/General Announcement). However, given the content is focused on clinical validation and scientific progress, it is often categorized as an Investor Presentation (IP) if it were a slide deck, or an Earnings Release (ER) if it were tied to a reporting period. Since it is a press release announcing scientific progress and validation, and not a formal financial statement or a transcript, RNS is the safest fallback. Upon re-evaluation, press releases announcing significant scientific milestones or clinical data are often classified as Investor Presentations (IP) if they contain substantial data/analysis, or sometimes ER if they are used as the primary communication vehicle for non-earnings news. Given the structure and focus on published data, it functions as an update for investors. However, since it is explicitly announcing the *publication* of studies, and not a formal earnings report, RNS is the most accurate catch-all for non-standard announcements. Let's check ER: ER is for initial announcement of periodical financial results (key highlights only). This is not financial results. Let's check IP: Investor Presentation (detailed presentation for investors focusing on financials, strategy, and market position). This document summarizes external publications, which serves an investor relations function. Given the high level of detail summarizing two external studies, it leans towards an Investor Presentation (IP) or a general Regulatory Filing (RNS). Since it is a press release format, RNS is the standard classification for non-periodic, non-specific corporate news releases.
2021-02-09 English
Inside Information / Information on annual revenues
Earnings Release Classification · 98% confidence The document is titled "MAUNA KEA TECHNOLOGIES REPORTS FOURTH QUARTER AND FULL YEAR 2020 SALES" and contains detailed financial figures, sales summaries, unit sales data, and commentary from the CEO regarding the performance for the fourth quarter and the full fiscal year 2020. This structure—presenting key financial metrics for a completed reporting period (quarterly and annually) immediately following the period close—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), as it focuses on sales highlights and key figures rather than full IFRS statements, and it is not a transcript (CT) or a presentation (IP). Since it is the initial announcement of periodical financial results, ER is the most appropriate classification. Q4 2020
2021-01-21 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 98% confidence The document is titled "MAUNA KEA TECHNOLOGIES PRESENTE SON CHIFFRE D'AFFAIRES DU QUATRIEME TRIMESTRE ET DE L'EXERCICE 2020" (Mauna Kea Technologies presents its revenue for the fourth quarter and the 2020 fiscal year). It contains detailed financial figures, revenue breakdowns by product type (systems, consumables, services) and geography for Q4 2020 and the full year 2020, along with commentary from the CEO. This structure is characteristic of an Earnings Release (ER), which is the initial announcement of periodical financial results, often focusing on key figures like revenue before the full, audited report (10-K) or comprehensive interim report (IR). Since it focuses specifically on quarterly and annual revenue figures and highlights, it fits the ER definition best, rather than the comprehensive IR or the formal 10-K. Q4 2020
2021-01-21 French
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "Mauna Kea Technologies publie son calendrier financier 2021" (Mauna Kea Technologies publishes its 2021 financial calendar). It explicitly lists future dates for the release of financial results (Q4/Annual 2020, Q1 2021, H1 2021, Q3 2021) and other financial events. This is not the actual report (like 10-K or IR), but an announcement about *when* reports will be published. According to Rule 2, a short document announcing the publication timing of reports should be classified as a Report Publication Announcement (RPA).
2021-01-11 French
Inside Information / Other news releases
Report Publication Announcement Classification · 99% confidence The document is titled "Mauna Kea Technologies Announces its 2021 Financial Calendar" and explicitly states that it announces the publication of the financial calendar, listing dates for future sales reports and financial results releases. It is not the financial report itself (like 10-K or IR), nor is it a transcript (CT) or a general earnings release (ER) which would contain the actual results. Since the core purpose of this short document is to announce *when* future reports will be published, it fits the definition of a Report Publication Announcement (RPA). The document length (3871 chars) also supports the 'MENU VS MEAL' rule, suggesting it's an announcement rather than the full report.
2021-01-11 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.